Acurx Pharmaceuticals, Inc. — Form D

Acurx Pharmaceuticals, Inc. of STATEN ISLAND, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-17. The offering totals $6.0M, of which $455K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Paul G BaehrDirectorWhite Plains, NY
Michael G DuffyDirectorWhite Plains, NY
Anthony G JadhonDirectorWhite Plains, NY
Katie G JadhonDirectorWhite Plains, NY
Mark G RathjenDirectorWhite Plains, NY
Carl G SailerDirectorWhite Plains, NY
John G TerranaDirectorWhite Plains, NY
David LuciDirectorJersey City, NJ
ROBERT G SHAWAHExecutive OfficerSTATEN ISLAND, NY
JAMES H DONOHUEDirectorSTATEN ISLAND, NY
CARL H SAILERDirectorSTATEN ISLAND, NY
JOSEPH H SCODARIDirectorSTATEN ISLAND, NY
ROBERT J DELUCCIADirectorSTATEN ISLAND, NY
ROBERT J DELUCCIAExecutive OfficerSTATEN ISLAND, NY
THOMAS H HARRISONDirectorSTATEN ISLAND, NY
JACK H DEANDirectorSTATEN ISLAND, NY
DAVID P LUCIDirectorSTATEN ISLAND, NY
DAVID P LUCIExecutive OfficerSTATEN ISLAND, NY
Robert ShawahExecutive OfficerSuwanee, GA
Robert DeLucciaDirectorWhite Plains, NY
Thomas HarrisonRelated PersonStaten Island, NY
David P. LuciRelated PersonStaten Island, NY
Robert J. DeLucciaRelated PersonStaten Island, NY
Robert G. ShawahRelated PersonStaten Island, NY
Jack H. DeanRelated PersonStaten Island, NY

Other filings by this issuer (9)

FiledFormOfferingSold
2026-04-29D$4.6M$4.6M
2025-06-27D$4.0M$4.0M
2025-05-20D$12.0M
2025-03-21D$3.4M$3.4M
2025-01-17D$2.4M$2.4M
2019-10-30D/A$7.8M$7.8M
2018-10-30D/A$7.0M$3.8M
2018-05-31D/A$7.0M$2.9M
2018-04-03D$7.0M$2.1M

More